<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00801645</url>
  </required_header>
  <id_info>
    <org_study_id>SNF 3200B0-103853</org_study_id>
    <nct_id>NCT00801645</nct_id>
  </id_info>
  <brief_title>Effects of Exercise on Arterial Function and Insulin Resistance Syndrome in Pre-pubertal Obese Children</brief_title>
  <official_title>Effects of Aerobic Exercise Training on Arterial Function and Insulin Resistance Syndrome in Obese Children: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss National Science Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this project is to investigate the effects of an exercise program on&#xD;
      arterial function and cardiovascular diseases risk factors in obese and lean pre-pubertal&#xD;
      children. This information will be used to underpin prevention strategies to reduce&#xD;
      cardiovascular diseases in overweight youth.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction: cardiovascular diseases (CVD) are the major contributor to the global burden of&#xD;
      non-communicable diseases, one third of all global death being attributed to CVD. Childhood&#xD;
      obesity poses a major public health problem and there is increasing evidence that foundation&#xD;
      of cardiovascular diseases lays early in life in obese children. There is therefore an urgent&#xD;
      need to identify effective prevention strategies. Physical activity is recognized as major&#xD;
      determinants of cardiovascular health in adults and adolescents however, little is known in&#xD;
      young children. The main purpose of this project is to investigate the effects of a 3-month&#xD;
      exercise training program on arterial function and cardiovascular diseases risk factors in&#xD;
      obese and lean children.&#xD;
&#xD;
      Methods: This is a randomized controlled trial including 4 groups of pre-pubertal children&#xD;
      aged 6 to 11 years old: 1) obese exercise, 2) obese control, 3) lean exercise, and 4) lean&#xD;
      control. The exercise groups engage in aerobic exercise training three 60-minute sessions per&#xD;
      week for 12 weeks, in addition of school physical education. Training sessions consist of 30&#xD;
      minutes of aerobic exercise (walking, running, games, swimming), followed by strength&#xD;
      training and stretching. Controls are relatively inactive. After the 3-month intervention,&#xD;
      the obese control group engages in an identical 12-week exercise program and the obese&#xD;
      exercise group is encouraged to continue for a total of 6 months. Primary measures include:&#xD;
      24-hour ambulatory systolic and diastolic blood pressure; endothelial function and mechanical&#xD;
      indices of the brachial and carotid arteries using a B-mode ultrasound imager; central blood&#xD;
      pressure and pulse wave velocity by tonometry of aplanation. Other measures include: body&#xD;
      composition, physical activity, cardio-respiratory fitness, nutrition, quality of life, and&#xD;
      fasting blood lipids, insulin, glucose, markers of vascular function and inflammation.&#xD;
      Testing is performed at baseline, 3, 6 and 24 months in obese children and at baseline and 3&#xD;
      months in lean children.&#xD;
&#xD;
      We hypothesize that exercise training will result in improved arterial function, body&#xD;
      composition and markers of the metabolic syndrome in obese children. This information will be&#xD;
      used to underpin prevention strategies to reduce CVD risk factors in this high-risk&#xD;
      population.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Arterial function</measure>
    <time_frame>0-3-6-24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>0-3-6-24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>0-3-6-24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory fitness</measure>
    <time_frame>0-3-6-24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>0-3-6-24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>0-3-6-24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lipids</measure>
    <time_frame>0-3-6-24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biological markers of endothelial function</measure>
    <time_frame>0-3-6-24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High sensitive C-reactive protein</measure>
    <time_frame>0-3-6-24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting and ambulatory blood pressure</measure>
    <time_frame>0-3-6-24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Obese exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lean Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lean Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>The exercise groups engage in aerobic exercise training three 60-minute sessions per week for 12 weeks, in addition of school physical education. Training sessions consist of 30 minutes of aerobic exercise (walking, running, games, swimming), followed by strength training and stretching.</description>
    <arm_group_label>Lean Exercise</arm_group_label>
    <arm_group_label>Obese exercise</arm_group_label>
    <other_name>Physical activity</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  obese children: Pre-pubertal (Tanner stage 1), BMI &gt; 97th age- and gender-specific&#xD;
             percentile (Kromeyer-Hauschild et al. 2001).&#xD;
&#xD;
          -  lean subjects: Pre-pubertal (Tanner stage 1), BMI &gt; 10th and &lt; 90th age- and&#xD;
             gender-specific percentile.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  being involved in any weight control, physical activity, or behavioral therapy&#xD;
&#xD;
          -  familial history of dyslipidemia or essential hypertension&#xD;
&#xD;
          -  medications or hormones, which may influence cardiovascular function, body&#xD;
             composition, lipid or glucose metabolism&#xD;
&#xD;
          -  orthopedic affection limiting physical activity&#xD;
&#xD;
          -  genetic disorder or a chronic disease&#xD;
&#xD;
          -  following a therapy for psychiatric problems&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maurice Beghetti, PD</last_name>
    <role>Study Director</role>
    <affiliation>Pediatric Cardiology Unit, Departement of Child and Adolescent, University Hospital, Geneva</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nathalie J Farpour-Lambert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pediatric Cardiology Unit, Department of Child and Adolescent, University Hospital, Geneva</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Child and Adolescent, University Hospital of Geneva</name>
      <address>
        <city>Geneva</city>
        <zip>1205</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <study_first_submitted>December 2, 2008</study_first_submitted>
  <study_first_submitted_qc>December 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2008</study_first_posted>
  <last_update_submitted>January 4, 2012</last_update_submitted>
  <last_update_submitted_qc>January 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Nathalie Farpour-Lambert</investigator_full_name>
    <investigator_title>Head of the Obesity Care Program</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Cardiovascular disease</keyword>
  <keyword>Endothelial function</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Exercise</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Metabolic syndrome</keyword>
  <keyword>Children</keyword>
  <keyword>Pediatric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

